|
Match
|
Document |
Document Title |
|
|
5631006 |
Immunotherapy protocol of culturing leukocytes in the presence of interleukin-2 in a hollow fiber cartridge
An immunotherapy protocol in which leukocytes are cultured in the presence of interleukin-2 in a hollow fiber cartridge perfusion system for at least four days to achieve a harvest yield of at...
|
|
|
5631009 |
Porcine adipocyte antigens and their use in the immunological control of fat
Antigens present in the plasma membrane of mature porcine white adipocytes, which are not present in porcine liver, kidney, spleen, brain, cardiac muscle, skeletal muscle or lung or in porcine...
|
|
|
5629198 |
Anti-HIV agent
The invention relates to an anti-HIV agent comprising, as an active ingredient, at least one porphyrin derivative selected from the following derivatives (A) and (B): (A) porphyrins modified...
|
|
|
5626881 |
Humate dietary supplement
Humate, a composition of primarily humic acids, carbon, and organic matter, is used as a human dietary supplement. The humate may be mixed with food, liquid drinks, or flavoring and ingested. The...
|
|
|
5622779 |
Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis and methods of using same
The present invention provides a substantially purified cellular factor that can regulate the expression of genes that encode proteins involved in cholesterol metabolism. The invention also...
|
|
|
5609873 |
Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions
The invention relates to a cosmetic or dermatological composition, as well as a cell culture medium. This composition and this medium contain an ecdysteroid, an ecdysteroid derivative or a plant or...
|
|
|
5607840 |
Protein hydrolysate derived from mucosa tissue
A protein hydrolyzate is produced from mucosa tissue of pigs, cattle or sheep by providing an aqueous mixture of the tissue, hydrolyzing the tissue with a proteolytic enzyme at a salt concentration...
|
|
|
5599558 |
Selecting amounts of platelet releasate for efficacious treatment of tissue
A method of making a platelet releasate product is disclosed involving performing an assay on a platelet releasate sample for a component of the releasate and forming platelet releasate product by...
|
|
|
5578307 |
Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use
Shaped articles containing plant extract(s), in particular pellets, are formed by dispersing the plant extract(s) in a matrix predominantly composed of a skeleton builder, i.e. collagen, gelatin,...
|
|
|
5576026 |
Lumbricus product and method of making same
A method of making a lumbricus powder wherein there is provided a quantity of worms which are cleaned and then masticated. The masticated worms are then hydrolyzed, this being accomplished by...
|
|
|
5569581 |
Alteration and prediction of male fertility using seminal plasma and its components
Two-dimensional polyacrylamide gel electrophoresis of seminal plasma samples indicate that two proteins (26 kDa, pI 6.2; 55 kDa, pI 4.5) predominated in higher fertility bulls and two proteins (16...
|
|
|
5560935 |
Physiologically active substances extracted from activated tissues
The present invention provides a physiologically active substance which inhibits plasma kallikrein production, improves peripheral blood flow, and exhibits analgesic, antiinflammatory and...
|
|
|
5560915 |
Composition for treating IgE mediated allergies comprising substance P and allergen
The invention provides the therapeutic compositions and a treatment method for alleviating IgE mediated allergis by administration of substance P together with a specific allergen are thereby...
|
|
|
5543139 |
5.5 kD TNF degradation product
A particular TNF degradation product is effective as a cytotoxin with respect both to TNF-sensitive and TNF-resistant tumor cells. Pharmaceutical compositions containing this degradation product...
|
|
|
5532141 |
Process for obtaining ganglioside lipids
A method is taught whereby improved yields of lipid containing molecules, such as gangliosides, are obtained. Involved is the treatment of neural tissue from animals afflicted with GM1...
|
|
|
5529792 |
Inhibitors of endothelial cell proliferation
In order to isolate an inhibitor of the proliferation of endothelial cells from the tissue of vertebrates the tissue selected as the starting material e.g. embryonic tissue or adult brain tissue...
|
|
|
5514657 |
Topical antibacterial preparation
A topical antibacterial preparation for treating infected wounds and for advancing their healing comprises silver sulfadiazine (SSD) and collagen, in which the w/w ratio of collagen to SSD ranges...
|
|
|
5492695 |
Vaccinating cats against Dirofilaria immitis with an L4 homogenate
It has been found that hosts which are susceptible to nematode parasite infections can readily be protected from such infections when the parasites are not adapted for a parasite/host relationship...
|
|
|
5484601 |
Flowable demineralized bone powder composition and its use in bone repair
A flowable demineralized bone powder composition is provided for use in surgical bone repair.
|
|
|
5445824 |
Physiological activating material extracted from coral sand
The inventor found for the first time that an extracted material from coral sand occurring in nature contains physiological activating substances. Based on this observation, in a process according...
|
|
|
5427940 |
Engineered cells producing insulin in response to glucose
The present disclosure relates to the application of genetic engineering to provide artificial β cells, i.e. cells which can secrete insulin in response to glucose. This is achieved preferably...
|
|
|
5425951 |
Method of reconstituting lyophilized cells
A process and medium are disclosed for the lyophilization of cells which comprises the use of solutions including monosaccharide hexoses and pentoses, and/or biocompatible amphipathic polymers to...
|
|
|
5422393 |
Natriuretic hormone
A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a...
|
|
|
5415874 |
Natural killer cell lines and clones with antigen specificity
Lymphocytes of NK phenotype were cultured with stimulator cell lines in the presence of growth factor containing medium. The resulting lines and clones derived from these lines expressed CD16...
|
|
|
5405616 |
Means for containing active substances, having a shell of hydrophilic macromolecules, active substances and process for preparation thereof
The invention is directed to exactly dosable molded particles, for example granulates or pellets comprising hydrophilic macromolecules, active materials and additionally further pharmaceutically...
|
|
|
5405608 |
Pharmaceutical composition for treating thermal injuries of warm blooded mammals including humans
This invention relates to a pharmaceutical composition mainly used for treating thermal injuries of warm blooded mammals and human. It is composed of 3 to 15% by weight of beeswax and 85 to 97% by...
|
|
|
5401502 |
Pellets containing plant extracts, process of making same and their pharmaceutical peroral or cosmetic use
Plant extract containing pellets are formed by a dispersion of plant extract or extracts in a matrix, principally comprising a skeleton builder namely collagen, gelatin, fractionated gelatin, a...
|
|
|
5397578 |
Method of treatment of chronic purulent inflammations of ear in children
A method for treating chronic, purulent, middle otitis in children, comprising administering, through a perforation into a middle ear cavity, a freshly prepared donor plasma of one of the parents...
|
|
|
5397773 |
Photoprotective composition containing yeast extract
A composition and method for protecting skin from the damaging of UV or solar radiation, comprising topical application to the skin of a composition containing a yeast cell wall extract.
|
|
|
5395851 |
Tree wound coating composition
A coating composition for application to tree wounds, such as pruning wounds of living trees is provided. The composition is non-phytotoxic and provides extended protection against fungal...
|
|
|
5387415 |
Aloe vera juice containing pellets process for production thereof and the use thereof as pharmaceutical, cosmetic and peroral agents
Aloe vera juice containing pellets are formed by a dispersion of aloe vera juice in a matrix, principally comprising a skeleton builder namely collagen, gelatin, fractionated gelatin, a collagen...
|
|
|
5384129 |
Pellets containing dihydropyridine derivatives process for the production thereof and use as rapid action dosage in heart and circulatory diseases
The present invention is directed to dihydropyridine derivative containing pellets comprising a dispersion of the dihydropyridine derivatives in a matrix which is substantially formed of a skeleton...
|
|
|
5382514 |
In vivo angiogenesis assay
A method of performing in vivo angiogenesis assays which involves the use of a matrix material which can be maintained in an injectable solution form at a temperature below that of a host and which...
|
|
|
5360606 |
Biological inoculant effective against alternaria
Alternaria disease on plant leaves and stems is controlled by inoculating the plants with an effective amount of a biologically pure culture of a Pseudomonas cepacia strain. Ps. cepacia strain AMMD...
|
|
|
5344647 |
Strain of microorganism having antimicrobial activity
The invention provides Bacillus subtilis strains NCIB 12375, NCIB 12376 and NCIB 12616, which have improved antimicrobial activity. The invention also relates to the use of such strains in the...
|
|
|
5336492 |
Bacillus thuringiensis isolates denoted B.T. PS81F, active against lepidopteran pests
A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe, The DNA encoding the B.t. toxin can be used to transform various...
|
|
|
5334499 |
Methods of extracting, amplifying and detecting a nucleic acid from whole blood or PBMC fraction
A nucleic acid is rapidly extracted from whole blood or a peripheral blood mononuclear cell (PBMC) fraction thereof. Extraction from the PBMC fraction is accomplished by heating the fraction at or...
|
|
|
5332572 |
Method for protection of swine against pleuropneumonia
The respiratory mucosa of swine are sensitized for the production of protective IgA antibodies on infection with Actinobacillus (Haemophilus) pleuropneumoniae by prior administration of a vaccine...
|
|
|
5324524 |
Yeast derived mitogen
A substantially pure mitogen is obtained from yeast. Medicaments containing the same and methods of treatment using the same are described.
|
|
|
5304464 |
Protein complex enhancing sperm motility
The present invention relates to a macromolecule of proteinaceous nature which activates sperm motility, a process for the preparation thereof by purification of the macromolecule from...
|
|
|
5294544 |
Biologically active factor
The invention comprises a factor having the following characteristics: a) It inhibits granulocyte-macrophage colony and cluster formation; b) It has a molecular weight of about 8 kDa as...
|
|
|
5292523 |
Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
The invention provides a method for the growth promotion of animals, comprising orally administering into animals killed microbial cells of bacteria belonging to the genus Clostridium, and also...
|
|
|
5286498 |
Rapid extraction of ciguatoxin from contaminated tissues
The present invention relates to methods for the rapid extraction of ciguatoxins from tissue samples. In one embodiment, a tissue sample is extracted with a first solvent to solubilize and extract...
|
|
|
5279836 |
Topical use of calcitonin for the preparation of medications in senile idiopathic cataract and a pharmaeutical composition thereof
A new use of calcitonin, as an active principle, is provided for the preparation of topically appliable medications in the treatment of pre-senile and senile idiopathic cataract; and a...
|
|
|
5246715 |
Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
A composition of matter useful as an inhibitor of blood platelet aggregation, for the treatment of various clinical disorders such as thrombotic, inflammatory and immunological disorders. This...
|
|
|
5240714 |
Non-digoxin-like Na.sup.+, K.sup.+ -ATPase inhibitory factor
A highly purified, Na + ,K + -ATPase inhibitory factor is disclosed herein. The factor does not cross-react with anti-digoxin antibody and exhibits uniquely characteristic UV absorbance maxima at...
|
|
|
5234910 |
Acid inhibitor of bacterial origin
An acid inhibitor of bacterial origin which is effective in inhibiting acid secretion from gastric parietal cells; a method of producing this acid inhibitor; a method of administering the acid...
|
|
|
5225203 |
Pharmaceutical liquid composition containing Bezoar bovis
A pharmaceutical liquid composition such as suspension, gel, or sol preparation, contains Bezoar bovis, Dioscoreae rhizoma, Glycyrrhizae radix, Ginseng radix, Typhae Pollen, Massa medicata...
|
|
|
5223491 |
Method for revitalizing skin by applying topically water insoluble glucan
A method revitalizing skin by applying topically a substantially purified water insoluble glucan, extracted from yeast cell walls, dispersed within a carrier. Also, disclosed is a method for...
|
|
|
5186944 |
Therapeutic medicament for thrombosis
An efficient therapeutic medicament in a powdery form for thrombosis and related diseases is prepared by the steps of: removing dirty matters on the body surface and fecal mud in the digestive...
|